Skip to content
Search

Latest Stories

Diabetes drug prescriptions rises eight million since 2015, NHS report says

Nearly 60 million drugs were used to treat people with diabetes in England last year, increasing eight million since 2015-16, a report by the NHS revealed.

The latest data released by the NHS Business Service Authority (NHSBSA) showed that 57.9 million drugs were prescribed during 2020-21, costing the exchequer £1.19 billion. It accounted for 12.5 per cent of the total spend on all prescription items.


The data showed a steep increase from 2015-16, where 49.7 million diabetes items were prescribed for a cost of £958 million, accounting for 10.4 per cent of the total spend.

The study entitled ‘Prescribing for diabetes England 2015-2016 to 2020-2021’, also found that there were over 3.05 million identified patients, who were prescribed diabetes drugs, against 3 million patients in 2019-20, and 2.70 million in 2015-16.

It further revealed that most people who were prescribed drugs for diabetes last year lived in deprived areas.

The most common age group among the patients in 2020-21 was 70 to 74, higher than 65 to 69 registered in 2015-16.

Besides, cost of antidiabetic drugs increased by 62 per cent from £423m in 2015-16 to £686m last year.

In 2020-21, 43.1 million antidiabetic drug items were prescribed.

The most deprived areas in England have the highest number of identified patients being prescribed drugs used in treating diabetes in 2020-21.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less